A comparison of neuromuscular effects, tracheal intubating conditions, and reversibility of rapacuronium versus mivacurium in female patients.
Rapacuronium is a new, rapid-onset, short-duration, nondepolarizing neuromuscular blocking drug. We evaluated the intubating conditions at maximum block after the administration of rapacuronium or mivacurium in female patients undergoing laparoscopy. We also evaluated the neostigmine-induced reversibility of neuromuscular block after this single dose of rapacuronium or mivacurium.
Vanacker
Bernard F
BF
Department of Anesthesiology, University Hospitals KULeuven, Leuven, Belgium.
Geerts
Ester
E
Coppens
Steve
S
van Iersel
Mathijs
M
D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004311:Double-Blind Method; D005260:Female; D013509:Gynecologic Surgical Procedures; D006801:Humans; D007442:Intubation, Intratracheal; D007546:Isoquinolines / Q000037:antagonists & inhibitors; D010535:Laparoscopy; D000077590:Mivacurium; D009388:Neostigmine / Q000494:pharmacology; D019148:Neuromuscular Blockade; D003473:Neuromuscular Nondepolarizing Agents / Q000037:antagonists & inhibitors; D014673:Vecuronium Bromide / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors
D002800:Cholinesterase Inhibitors; D007546:Isoquinolines; D003473:Neuromuscular Nondepolarizing Agents; D009388:Neostigmine; D000077590:Mivacurium; D014673:Vecuronium Bromide; C082938:rapacuronium